The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tumor Blood Testing Market Research Report 2025
Synopsis
The global Tumor Blood Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Tumor Blood Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Blood Testing.
Report Scope
The Tumor Blood Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Blood Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Blood Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Segment by Type
Blood Protein Testing
Tumor Marker Testing
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Blood Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Tumor Blood Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Tumor Blood Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Blood Testing.
Report Scope
The Tumor Blood Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Blood Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Blood Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
Segment by Type
Blood Protein Testing
Tumor Marker Testing
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Blood Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Blood Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Protein Testing
1.2.3 Tumor Marker Testing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tumor Blood Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Blood Testing Market Perspective (2019-2030)
2.2 Tumor Blood Testing Growth Trends by Region
2.2.1 Global Tumor Blood Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Blood Testing Historic Market Size by Region (2019-2024)
2.2.3 Tumor Blood Testing Forecasted Market Size by Region (2025-2030)
2.3 Tumor Blood Testing Market Dynamics
2.3.1 Tumor Blood Testing Industry Trends
2.3.2 Tumor Blood Testing Market Drivers
2.3.3 Tumor Blood Testing Market Challenges
2.3.4 Tumor Blood Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Blood Testing Players by Revenue
3.1.1 Global Top Tumor Blood Testing Players by Revenue (2019-2024)
3.1.2 Global Tumor Blood Testing Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Blood Testing Revenue
3.4 Global Tumor Blood Testing Market Concentration Ratio
3.4.1 Global Tumor Blood Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Blood Testing Revenue in 2023
3.5 Tumor Blood Testing Key Players Head office and Area Served
3.6 Key Players Tumor Blood Testing Product Solution and Service
3.7 Date of Enter into Tumor Blood Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Blood Testing Breakdown Data by Type
4.1 Global Tumor Blood Testing Historic Market Size by Type (2019-2024)
4.2 Global Tumor Blood Testing Forecasted Market Size by Type (2025-2030)
5 Tumor Blood Testing Breakdown Data by Application
5.1 Global Tumor Blood Testing Historic Market Size by Application (2019-2024)
5.2 Global Tumor Blood Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Blood Testing Market Size (2019-2030)
6.2 North America Tumor Blood Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Blood Testing Market Size by Country (2019-2024)
6.4 North America Tumor Blood Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Blood Testing Market Size (2019-2030)
7.2 Europe Tumor Blood Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Blood Testing Market Size by Country (2019-2024)
7.4 Europe Tumor Blood Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Blood Testing Market Size (2019-2030)
8.2 Asia-Pacific Tumor Blood Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Blood Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Blood Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Blood Testing Market Size (2019-2030)
9.2 Latin America Tumor Blood Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Blood Testing Market Size by Country (2019-2024)
9.4 Latin America Tumor Blood Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Blood Testing Market Size (2019-2030)
10.2 Middle East & Africa Tumor Blood Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Blood Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Blood Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Guardant Health
11.1.1 Guardant Health Company Detail
11.1.2 Guardant Health Business Overview
11.1.3 Guardant Health Tumor Blood Testing Introduction
11.1.4 Guardant Health Revenue in Tumor Blood Testing Business (2019-2024)
11.1.5 Guardant Health Recent Development
11.2 Trovagene
11.2.1 Trovagene Company Detail
11.2.2 Trovagene Business Overview
11.2.3 Trovagene Tumor Blood Testing Introduction
11.2.4 Trovagene Revenue in Tumor Blood Testing Business (2019-2024)
11.2.5 Trovagene Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Detail
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Tumor Blood Testing Introduction
11.3.4 Genomic Health Revenue in Tumor Blood Testing Business (2019-2024)
11.3.5 Genomic Health Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Tumor Blood Testing Introduction
11.4.4 Roche Revenue in Tumor Blood Testing Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Detail
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Tumor Blood Testing Introduction
11.5.4 Bio-Techne Revenue in Tumor Blood Testing Business (2019-2024)
11.5.5 Bio-Techne Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Detail
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Tumor Blood Testing Introduction
11.6.4 Pathway Genomics Revenue in Tumor Blood Testing Business (2019-2024)
11.6.5 Pathway Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Tumor Blood Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Protein Testing
Table 3. Key Players of Tumor Marker Testing
Table 4. Key Players of Others
Table 5. Global Tumor Blood Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Tumor Blood Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Tumor Blood Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Tumor Blood Testing Market Share by Region (2019-2024)
Table 9. Global Tumor Blood Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Tumor Blood Testing Market Share by Region (2025-2030)
Table 11. Tumor Blood Testing Market Trends
Table 12. Tumor Blood Testing Market Drivers
Table 13. Tumor Blood Testing Market Challenges
Table 14. Tumor Blood Testing Market Restraints
Table 15. Global Tumor Blood Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Tumor Blood Testing Market Share by Players (2019-2024)
Table 17. Global Top Tumor Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2023)
Table 18. Ranking of Global Top Tumor Blood Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Tumor Blood Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Tumor Blood Testing Product Solution and Service
Table 22. Date of Enter into Tumor Blood Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tumor Blood Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Tumor Blood Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Tumor Blood Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Tumor Blood Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Tumor Blood Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Tumor Blood Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Tumor Blood Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Tumor Blood Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Tumor Blood Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Tumor Blood Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Tumor Blood Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Tumor Blood Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Tumor Blood Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Tumor Blood Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Tumor Blood Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Tumor Blood Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Tumor Blood Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Tumor Blood Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Tumor Blood Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Tumor Blood Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Guardant Health Company Detail
Table 48. Guardant Health Business Overview
Table 49. Guardant Health Tumor Blood Testing Product
Table 50. Guardant Health Revenue in Tumor Blood Testing Business (2019-2024) & (US$ Million)
Table 51. Guardant Health Recent Development
Table 52. Trovagene Company Detail
Table 53. Trovagene Business Overview
Table 54. Trovagene Tumor Blood Testing Product
Table 55. Trovagene Revenue in Tumor Blood Testing Business (2019-2024) & (US$ Million)
Table 56. Trovagene Recent Development
Table 57. Genomic Health Company Detail
Table 58. Genomic Health Business Overview
Table 59. Genomic Health Tumor Blood Testing Product
Table 60. Genomic Health Revenue in Tumor Blood Testing Business (2019-2024) & (US$ Million)
Table 61. Genomic Health Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Tumor Blood Testing Product
Table 65. Roche Revenue in Tumor Blood Testing Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Bio-Techne Company Detail
Table 68. Bio-Techne Business Overview
Table 69. Bio-Techne Tumor Blood Testing Product
Table 70. Bio-Techne Revenue in Tumor Blood Testing Business (2019-2024) & (US$ Million)
Table 71. Bio-Techne Recent Development
Table 72. Pathway Genomics Company Detail
Table 73. Pathway Genomics Business Overview
Table 74. Pathway Genomics Tumor Blood Testing Product
Table 75. Pathway Genomics Revenue in Tumor Blood Testing Business (2019-2024) & (US$ Million)
Table 76. Pathway Genomics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Blood Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tumor Blood Testing Market Share by Type: 2023 VS 2030
Figure 3. Blood Protein Testing Features
Figure 4. Tumor Marker Testing Features
Figure 5. Others Features
Figure 6. Global Tumor Blood Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Tumor Blood Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Tumor Blood Testing Report Years Considered
Figure 12. Global Tumor Blood Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Tumor Blood Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Tumor Blood Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Tumor Blood Testing Market Share by Players in 2023
Figure 16. Global Top Tumor Blood Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Blood Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Tumor Blood Testing Revenue in 2023
Figure 18. North America Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Tumor Blood Testing Market Share by Country (2019-2030)
Figure 20. United States Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Tumor Blood Testing Market Share by Country (2019-2030)
Figure 24. Germany Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Tumor Blood Testing Market Share by Region (2019-2030)
Figure 32. China Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Tumor Blood Testing Market Share by Country (2019-2030)
Figure 40. Mexico Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Tumor Blood Testing Market Share by Country (2019-2030)
Figure 44. Turkey Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Tumor Blood Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Guardant Health Revenue Growth Rate in Tumor Blood Testing Business (2019-2024)
Figure 47. Trovagene Revenue Growth Rate in Tumor Blood Testing Business (2019-2024)
Figure 48. Genomic Health Revenue Growth Rate in Tumor Blood Testing Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Tumor Blood Testing Business (2019-2024)
Figure 50. Bio-Techne Revenue Growth Rate in Tumor Blood Testing Business (2019-2024)
Figure 51. Pathway Genomics Revenue Growth Rate in Tumor Blood Testing Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
